vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and NNN REIT, INC. (NNN). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $240.4M, roughly 1.1× NNN REIT, INC.). NNN REIT, INC. runs the higher net margin — 39.1% vs 1.4%, a 37.7% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs 4.1%). Over the past eight quarters, NNN REIT, INC.'s revenue compounded faster (5.3% CAGR vs 5.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
NNN Reit, Inc. is a real estate investment trust that invests primarily in restaurant properties that are subject to long-term triple net leases, usually under leaseback arrangements. It is organized in Maryland with its principal office in Orlando, Florida.
ACAD vs NNN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $240.4M |
| Net Profit | $3.6M | $94.0M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 61.0% |
| Net Margin | 1.4% | 39.1% |
| Revenue YoY | 9.7% | 4.1% |
| Net Profit YoY | — | -2.6% |
| EPS (diluted) | $0.02 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $240.4M | ||
| Q4 25 | $284.0M | $238.4M | ||
| Q3 25 | $278.6M | $230.2M | ||
| Q2 25 | $264.6M | $226.8M | ||
| Q1 25 | $244.3M | $230.9M | ||
| Q4 24 | $259.6M | $218.5M | ||
| Q3 24 | $250.4M | $218.6M | ||
| Q2 24 | $242.0M | $216.8M |
| Q1 26 | $3.6M | $94.0M | ||
| Q4 25 | $273.6M | $96.0M | ||
| Q3 25 | $71.8M | $96.8M | ||
| Q2 25 | $26.7M | $100.5M | ||
| Q1 25 | $19.0M | $96.5M | ||
| Q4 24 | $143.7M | $97.9M | ||
| Q3 24 | $32.8M | $97.9M | ||
| Q2 24 | $33.4M | $106.7M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | 61.0% | ||
| Q4 25 | 6.1% | 62.3% | ||
| Q3 25 | 12.8% | 64.0% | ||
| Q2 25 | 12.2% | 66.0% | ||
| Q1 25 | 7.9% | 62.3% | ||
| Q4 24 | 59.1% | 65.8% | ||
| Q3 24 | 12.6% | 65.7% | ||
| Q2 24 | 12.6% | 70.2% |
| Q1 26 | 1.4% | 39.1% | ||
| Q4 25 | 96.3% | 40.2% | ||
| Q3 25 | 25.8% | 42.1% | ||
| Q2 25 | 10.1% | 44.3% | ||
| Q1 25 | 7.8% | 41.8% | ||
| Q4 24 | 55.4% | 44.8% | ||
| Q3 24 | 13.1% | 44.8% | ||
| Q2 24 | 13.8% | 49.2% |
| Q1 26 | $0.02 | $0.50 | ||
| Q4 25 | $1.61 | $0.51 | ||
| Q3 25 | $0.42 | $0.51 | ||
| Q2 25 | $0.16 | $0.54 | ||
| Q1 25 | $0.11 | $0.51 | ||
| Q4 24 | $0.86 | $0.52 | ||
| Q3 24 | $0.20 | $0.53 | ||
| Q2 24 | $0.20 | $0.58 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $4.4B |
| Total Assets | $1.6B | $9.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $4.6M | ||
| Q4 25 | $177.7M | $5.0M | ||
| Q3 25 | $258.0M | $157.9M | ||
| Q2 25 | $253.6M | $6.0M | ||
| Q1 25 | $217.7M | $5.1M | ||
| Q4 24 | $319.6M | $8.7M | ||
| Q3 24 | $155.1M | $173.5M | ||
| Q2 24 | $177.1M | $2.1M |
| Q1 26 | — | $4.4B | ||
| Q4 25 | $1.2B | $4.4B | ||
| Q3 25 | $917.3M | $4.4B | ||
| Q2 25 | $822.4M | $4.4B | ||
| Q1 25 | $765.2M | $4.4B | ||
| Q4 24 | $732.8M | $4.4B | ||
| Q3 24 | $577.2M | $4.4B | ||
| Q2 24 | $516.7M | $4.2B |
| Q1 26 | $1.6B | $9.4B | ||
| Q4 25 | $1.6B | $9.4B | ||
| Q3 25 | $1.3B | $9.5B | ||
| Q2 25 | $1.2B | $9.1B | ||
| Q1 25 | $1.1B | $9.0B | ||
| Q4 24 | $1.2B | $8.9B | ||
| Q3 24 | $976.9M | $8.9B | ||
| Q2 24 | $914.1M | $8.7B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
